Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Study Outcomes News

Study Outcomes News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Study Outcomes. Real-time updates on events, politics, business and more.

First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis

May 9, 2023
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new efficacy and safety data from the Phase 3 QUASAR Induction Study...
Spring House British Columbia United States Craig Stoltz Jessicar Allegretti National Institutes Of Health
Source: prnewswire.com

Johnson & Johnson : First Phase 3 TREMFYA® (guselkumab) Data in Inflammatory Bowel Disease Show Positive Induction Results Among Patients with Moderately to Severely Active Ulcerative Colitis

May 9, 2023
That cause chronic inflammation of the gastrointestinal tract.6 Prolonged inflammation results in damage to the GI tract.6 The exact cause of IBD is unknown but may be the result of the immune... | May 9, 2023
United States Spring House Jessicar Allegretti Craig Stoltz National Institutes Of Health Colitis Center
Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science